MSI-high
|
disease |
|
Neoplastic Process
|
83
|
9
|
0.100 |
None |
0.971 |
35 |
3
|
1999 |
2019 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.100 |
None |
0.920 |
25 |
3
|
1994 |
2019 |
polyps
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Anatomical Abnormality
|
390
|
18
|
0.100 |
None |
0.955 |
22 |
|
2003 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.700 |
strong |
0.900 |
20 |
3
|
1994 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.700 |
None |
0.950 |
20 |
3
|
1994 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.400 |
None |
0.833 |
18 |
1
|
2000 |
2019 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.100 |
None |
0.941 |
17 |
1
|
1996 |
2019 |
Constitutional Mismatch Repair Deficiency Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Disease or Syndrome
|
6
|
1
|
0.340 |
definitive |
1.000 |
16 |
|
1998 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.100 |
None |
0.812 |
16 |
|
1998 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.400 |
None |
1.000 |
15 |
2
|
2001 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.857 |
14 |
|
2002 |
2019 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
1543
|
348
|
0.100 |
None |
1.000 |
12 |
|
1998 |
2019 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.200 |
None |
1.000 |
11 |
|
1997 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
1.000 |
11 |
2
|
2001 |
2019 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.490 |
None |
1.000 |
10 |
|
1997 |
2019 |
Malignant neoplasm of gastrointestinal tract
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
423
|
55
|
0.090 |
None |
0.889 |
9 |
4
|
1999 |
2019 |
Carcinoma, Transitional Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
623
|
12
|
0.090 |
None |
1.000 |
9 |
1
|
2001 |
2019 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.090 |
None |
1.000 |
9 |
|
2001 |
2019 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.060 |
None |
1.000 |
6 |
|
1997 |
2019 |
Urothelial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
449
|
10
|
0.060 |
None |
1.000 |
6 |
|
2006 |
2019 |
Hereditary Malignant Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
63
|
18
|
0.060 |
None |
0.667 |
6 |
|
2002 |
2019 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.050 |
None |
1.000 |
5 |
|
1997 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.050 |
None |
1.000 |
5 |
|
1997 |
2019 |
Oligospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
217
|
72
|
0.030 |
None |
1.000 |
3 |
3
|
2012 |
2019 |
Fragile X Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
194
|
11
|
0.020 |
None |
0.500 |
2 |
|
1996 |
2019 |